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Background: A genetic predisposition for certain tumour types has been proven for some dog breeds. Some
studies have suggested that this may also be true for the Golden retriever breed. The present study aimed to
examine a possible existence of a tumour (type) predisposition in the Dutch population of Golden retrievers by
evaluating annual estimated incidence rates compared to incidence rates from previous publications. A second aim
was to evaluate whether incidences of various tumours differed as related to the diagnostic method chosen, being
either cytology or histology.
Results: Tumours submitted to Utrecht University during the period 1998–2004 diagnosed either by means of
cytology (n = 2,529) or histology (n = 2,124), were related to an average annual Dutch kennel club population of
29,304 Golden retrievers.
Combining individual tumours from both the cytological and the histopathological data-set resulted in an annual
estimated incidence rate of 2,242 for 100,000 dog-years at risk regarding tumour development in general.
The most common cytological tumor diagnoses were ‘fat, possibly lipoma’ (35%), mast cell tumour (21%) and
non-Hodgkin lymphoma (10%). The most commonly diagnosed tumours by histology were mast cell tumour
(26%), soft tissue sarcomas (11%) and melanoma (8%). Both the cytological and histopathological data-sets,
showed variation; in patient age distribution, age of onset and incidence of various tumours.
Conclusion: Comparing our data with previous reports in non-breed-specified dog populations, the Golden
retriever breed shows an increased risk for the development of tumours in general, as well as an increased risk for
the development of specific tumour types, including the group of soft tissue sarcomas. Variations in age, location
and incidence of various tumours were observed between the two data-sets, indicating a selection bias for
diagnostic procedure.Background
Breeding from within a selected population of dogs can,
in a relative short period of time, give rise to a clear
change in phenotype which leads to breed development
[1,2] but may also cause an increase in the occurrence of
inherited diseases [3-7] such as cancer [8-12]. Clear evi-
dence exists for a breed-related predisposition to specific* Correspondence: K.M.Boerkamp@uu.nl
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stated.cancers, like histiocytic sarcomas in Bernese Mountain
dogs [10,13] and Flatcoated retrievers, [11] anal sac car-
cinomas in the English Cocker Spaniel [12,14] and
hemangiosarcomas in German Shepherd dogs [15]. For
the Golden retriever, an increased risk for the develop-
ment of cancer in general has been reported by some
[16,17], but not all studies [18,19]. Also, there are re-
ports on an increased risk for specific types of cancer in
Golden retrievers such as mast cell tumours (MCT)
[12,20] melanomas [21] and non-Hodgkin lymphomas
(NHL) [12,22,23] and suggestions of a predisposition toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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these studies are old age in the dogs, and the fact that
many studies were hospital-based and of small size.
Larger studies often rely on data from insurance com-
panies without verification of cytological or histopatho-
logical diagnoses. There is need for larger studies that
include examination of reports of diagnostic procedures
to obtain more solid data on the relative tumour inci-
dence. Such larger studies should enable better assess-
ment of a possible predisposition for specific tumour
types in breeds such as the Golden retriever. The results
may serve as means to improve health of the breed as well
as basis for comparative oncological research [12,16]. Fur-
thermore, regional variation in genetic population struc-
ture may appear [28].
Our aim was to obtain an estimate of the occurrence
of tumours and the distribution of tumour types in the
Golden retriever breed in the Netherlands. This was
done by accessing the archives (1998 – 2004) from two
of the main laboratories in the Netherlands – both lo-
cated at the Faculty of Veterinary Medicine in Utrecht -
that independently provide histopathological (Veterinary
Medical Diagnostic Center) - or cytological diagnostic
services (University Veterinary Diagnostic Laboratory).
Diagnostic management of dogs suspected to be af-
fected with neoplasia may preferentially be done by cyto-
logical examination of fine needle aspiration biopsies
(FNABs), by histopathological examination of resected
masses, or by both. Which method is chosen, depends
on multiple factors like accessibility of a possible neo-
plastic mass, the suspected tumour type, financial as-
pects, the availability of an experienced laboratory, etc.
Most studies that investigated the incidence of cancer in
dog populations have been based solely on histopath-
ology or are unclear about the diagnostic method used.
Our data-sets considered both histopathological- and
cytological examination; separately and combined.Table 1 Patients characteristics
Cytological
Number of tumours 2,52
● Mean/year 361
● Nr of dogs in which a second tumour was detected 69
● Nr of dogs in which a third tumour was detected 0
Male/male neutered 795/3
Female/female neutered 530/6
Median age 9.1 y
(min. 0.2 yrs, m
Number of malignant tumours 1,203 (4
Number of benign tumours 1,010 (4
Unknown 316 (12This retrospective study can, besides providing infor-
mation on potential health risks within the Golden
retriever, also be of help to veterinarians by providing
possible differential diagnoses.
Results
Of a total of 4,313 fine needle aspiration biopsies
(FNAB) of masses taken from Golden retriever dogs,
a total of 2,529 cases were diagnosed as a suspected
tumour (specific details are listed in Table 1). Remaining
biopsies were either non-diagnostic, mostly due to
poor cellularity of the specimen (n = 739; 17%) or diag-
nostic, but not considered to originate from a neoplasm
(n = 1,045; 24%). Of these non-neoplastic lesions, 51%
were diagnosed as inflammation.
Tumours diagnosed by cytology mostly originated from
the mesenchym (which included all benign and malignant
mesenchymal proliferations of bone and soft tissue). Sec-
ond most frequent were tumours that originated from
hematopoietic origin (which included histiocytomas, his-
tiocytic sarcomas, MCT, NHL, plasma cell tumours and
atypical lymphoid/histiocytic proliferations).
Tumours in the histological data-set were mostly of
hematopoietic origin (which included NHL, MCT, histio-
cytic sarcomas, splenic nodular hyperplasias/splenomas,
transmissable venereal tumours, thymomas, histiocytomas
(CCH) and plasma cell tumours) followed by epithelial le-
sions (including benign mammary tumours, perianal gland
adenomas, adenomas of other origin, ameloblastomas,
basal cell tumours, epitheliomas, insulinomas, papillomas,
trichoblastomas, trichoepitheliomas, and all (adeno-) car-
cinomas). Figure 1 shows this distribution into tissues of
origin for both cytological and histological data-sets.
Both data-sets were cross-referenced for double en-
tries and 54 cases were identified as being diagnosed
with cytology as well as histology. Of these 54 cases, 18
cases were diagnosed as MCT, 16 as being a soft tissuedata-set Histological data-set Combined set








ax.17.2 yrs) (min. 0.1 yrs, max.17.2 yrs)
8%) 1,262 (60%) 2,414
0%) 761 (36%) 1,768
%) 101 (5%) 417
Figure 1 Distribution into tissues of origin (in percentage) for the cytological- and histopathological diagnosed data-sets.
Origin: 1: Mesenchymal origin, 2: Hematopoietic/lymphoid origin, 3: Epithelial origin, 4: Neuroectodermal origin, 5: Other origins (gonadal, glial, NOS).
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anal gland tumours, two as CCH, one as amelanotic
melanoma and one as plasmacytoma.
The annual estimated incidence rate (EIR) was calcu-
lated, considering a population at risk of 29,304 dogs per
year. Based on an average of 657 annually diagnosed tu-
mours (using either cytology or histology), an EIR of
2,242 per 100,000 dogs was calculated for the occur-
rence of benign and malignant tumours in the Golden
retriever dog and an EIR of 1,174 per 100,000 dogs for
the development of only malignant tumours. Based
merely on tumours diagnosed by histology, an EIR of
1,034 was calculated for the occurrence of all tumours-
and an EIR of 615 for the development of malignant tu-
mours, respectively (Table 2). Based on cytology alone,Table 2 Estimated Incidence Rates (per 100,000 dog years at
histologically diagnosed tumours in the Golden retriever com
found in previous studies concerning the general dog popula
Histological data-set EIR Utrecht Incidence rate
Madison, Wisconsin [38]
General development of tumour 1,034









NHL 35 25for the development of malignant tumours an EIR of
586 was calculated (Table 3).
In general, benign tumours occurred at a younger age
than malignant tumours in the tumours diagnosed using
cytology (8.40 vs 8.95 yrs; Δ = 0.55 years, P < 0.001) as
well as the tumours diagnosed using histology (7.86 vs
8.35 yrs, Δ = 0.49 years, P < 0.002) (Figure 2). Also, a sig-
nificant difference was found in the median age of
tumour-diagnosis between the two diagnostic methods
(cytology: mean AOO: 8.76 yrs, histology: mean AOO:
8.19 yrs, Δ =0.57 yrs, P <0.001).
In both data-sets the median age at which tumours of
mesenchymal origin were diagnosed was higher (9 yrs;
range: 0–17.2) than that of tumours of hematopoietic ori-
gin (8.2 yrs (range: 0.2-14.9 yrs) by use of cytology and 7.0risk) of the most common types of benign and malignant
pared to Incidence Rates (per 100,000 dog years at risk)
tion
(Standardized)











114 19.9 (Males) 21.7
22.9 (Females)
Table 3 Estimated Incidence Rates (per 100,000 dog-years at risk) of the most common types of benign and malignant
cytologically diagnosed tumours in the Golden retriever compared to Incidence Rates (per 100,000 dog-years at risk)
found in previous studies concerning the general dog population










General development of tumour 1,232 2,671 760
Development of cancer 586 748 310 381
‘Fat, suspect lipoma’ 429 318
MCT 265 129
NHL 121 25 114 19.9 (Males) 21.7
and 22.9 (Females)
Perianal gland tumour 68
(Adeno) carcinoma 37
Mesenchymal proliferation, susp. STS 37 35 142 36
CCH 30 377
Melanoma 27 25 0.7 (Males) 0.6 (Females) 25
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show the age-distribution in all different tissues of origin.
The Male: Female ratio (M:F) of all histopathological
diagnosed tumours was 1.03 and that of all cytological
diagnosed tumours was 0.98. No significant difference in
gender was found for tumour development. The data
provided by the submitting clinic did not consistently in-
clude neutering status or date of neutering, prohibiting
an examination on the potential effect of age of neuter-
ing on tumour occurrence as published recently [29].
Significantly less frequently submitted were tumours
derived from internal organs (GI-tract and genital tract:
9%) compared to neoplasms that are more easy access-
ible (skin and adnexa, 54%).
Discussion
Estimated incidence rates
The percentage of malignant tumours versus benign tu-
mours was higher in the group diagnosed by histopathologyFigure 2 Age distribution of benign and malignant tumours as diagn
axis: Age of the dogs (years); vertical axis: Number of cases diagnosed. Darkthan in the group diagnosed by cytology. This differ-
ence might be caused by the relatively high percentage
of cases where cytological evaluation did not allow a
reliable distinction between a benign or malignant
neoplasm.
A striking finding was the existence of major variation
in representation for specific tumour types amongst the
two data sets. This could be a result of the clinician’s ex-
pectation of how likely it will be to obtain an accurate
diagnosis by either method, or the possibility that imme-
diate removal of tissue could be therapeutic. It may how-
ever also indicate a practice in which knowledge of the
tumour type by cytology decreases the likelihood that the
resected mass is submitted for histopathology. Future re-
search should examine this in more detail, since it influ-
ences the level of veterinary care and will also influence
epidemiological studies. The percentage of malignant tu-
mours as well as its EIR in the tumours diagnosed using
histopathology in the current study were higher than whatosed by means of histology (Left) or cytology (Right). Horizontal
grey: Benign tumours. Light grey: Malignant tumours.
Figure 3 Age-distribution in different tissues of origins in tumours diagnosed using histopathology. Origin: 1: Mesenchymal origin;
2: hematopoietic origin; 3: Epithelial origin, 4: Neuroectodermal origin; 5: Other (‘NOS’,gonadal origin; glial tumours).
Figure 4 Age-distribution in different tissues of origins in tumours diagnosed using cytology. Origin: 1: Mesenchymal origin; 2: hematopoietic
origin; 3: Epithelial origin, 4: Neuroectodermal origin; 5: Other (‘NOS’,gonadal origin; glial tumours).
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general dog-population; namely in Norway (2008) [18]
Italy (2009) [30,31] and Alameda (1968) [32,33]. This is
suggestive of a general breed-predisposition for malignant
tumours in the Golden retriever. This was also the conclu-
sion of a study from Reid-Smith et al. (Proceedings; The
incidence of neoplasia in the canine and patient popula-
tions of private veterinary practices in Southern Ontario
(2000)).
The diagnosis ‘Fat; possibly lipoma’ was clearly the
most commonly diagnosed benign lesion in the cyto-
logical data-set, which was also the case in a study in
Denmark [19] and the UK [34]. These last studies con-
sider a general dog population instead of one particular
breed and both include cases diagnosed by both
methods and not just histology. The EIR of 429 for ‘fat;
suspect lipoma’ found in the current study within our
cytological diagnosed tumours, was higher than the Inci-
dence Rate (IR) found in a study in England (IR: 317)
[34]. We could however not confirm this EIR in our
histolological data-set (EIR: 2.40). In a Norwegian study
that included only cases diagnosed using histology [35],
it was not the most common benign lesion. An explan-
ation for this marked difference may be that not all vet-
erinarians will have a cytologically diagnosed lipoma, or
a lesion that is suspect to be a lipoma based on mere
clinical examination, submitted for histopathological
evaluation in our study. After exclusion of all 879 cases
of ‘Fat, suspect lipoma’ from the cytological data-set,
only 15% of the tumours could be considered of mesen-
chymal origin instead of 45%. Epithelial proliferations
are then more common (20%) than mesenchymal le-
sions, which is consistent with our histopathological
dataset as well as with previous research [34].
Of all histologically confirmed tumours, CCH was the
most common benign tumour, although the EIR was
lower than was expected based on previous studies [34].
The fact that the EIR in the cytological data-set is much
lower than that of the histological data-set is surprising.
It illustrates that CCH is diagnosed more commonly
using histopathological than cytological evaluation. CCH
is a benign lesion [36,37], and a study in 2007 already
showed that it is easily recognizable using only cyto-
logical examination [36]. These lesions usually undergo
spontaneous regression in younger dogs [36,37] making
surgery unnecessary. It is our hope that CCH in future will
be more commonly diagnosed by cytology, leading to a
shift in the proportion diagnosed by the two methods.
In both data-sets, the most commonly observed malig-
nant lesion is the MCT. This is consistent with other
studies that evaluate the general dog-population, such as
the one in Denmark [19] and Norway [18,35]. However
the EIR calculated for MCT in both of the data-sets is
much higher in relation to the EIR of MCT in dogsirrespective of breed than would be expected on the
basis of previous reports [34]. This confirms the breed
predisposition for MCT, already mentioned in earlier
studies [12,20]. The same holds true for the relatively
high EIR for melanomas in the histopathological data-
set when compared to previous studies [21,38].
Another surprising finding was the high EIR (116) of
NHL This was much higher than the IR found in most
previous reports, with an IR of approximately 20 per
100,000 [30,32,38] and with a previous report by Teske
et.al, that reported the IR of NHL to be at least 33 [39]
for the general dog-population in The Netherlands. This
higher risk of NHL in the current study might be based
upon the fact that the diagnosis of NHL is usually made
by cytological evaluation, a diagnostic procedure very
often not included in previously reported epidemiologic
studies [32,34]. This observation of an higher than aver-
age risk supports the existence of a breed-predisposition
as has already been suspected [17,22,23]. The EIR found
in this study is comparable to the (age-standardized) IR
found recently by Dobson et al. (IR: 107) that most likely
included cytological diagnoses [34].
Cytology is not very effective in further differentiating
a mesenchymal lesion [40] because of morphological
similarities between reactive and neoplastic fibroblasts;
therefore the diagnosis ‘soft tissue sarcoma’ is usually
based on histological evaluation. The EIR for STS found
in our histologically diagnosed data-set (EIR: 114) is
higher than some previous publications in which an IR
of 35 was reported, [38] but somewhat lower than the IR
found by Dobson et al. (IR: 142) [34]. This last study,
however, used age-standardized IR, which we could not.
A breed predisposition for STS in the Golden retriever
is therefore still considered possible.
Of the STS-subtypes that could be identified by routine
histopathological evaluation in 1998–2004, the most fre-
quently found tumours were fibrosarcomas (n = 54; 23%),
hemangiosarcomas (n = 34; 15%) and neurofibrosarcomas
(9%), which is largely in accordance with literature [32].
However, in 40% of all STS further differentiation proved
impossible, so a more precise indication of a possible pre-
disposition for a specific subtype was impossible.
Additional value of combining both data-sets
In this study we attempted to evaluate and explain the
complementary value of combining results obtained by
different diagnostic method of choice; being both cyto-
logical and histological examination. We clearly estab-
lished that the incidence of NHL is underestimated in
the histological data-set. Also, the difference in incidence
in CCH as well as the diagnosis ‘Fat; suspect lipoma’ be-
tween the two data-sets, underlines the importance of
combining both methods when performing a biopsy-based
epidemiological study. The change of data registration
Table 4 Distribution of location of 2,124 tumours
diagnosed using histopathology
Location Frequency Percentage
Head (excluding skin/adnexa) 308 15
Skin and adnexa 1148 54
Mammae 187 9
Gastro-intestinal tract 72 3
Endocrine organs 12 0.6
Genital tract 118 6
Hematoproliferative system 58 3
Urogenital tract 12 0.6
Heart and lungs 6 0.3
Central nervous system 6 0.3
Soft tissue, other 143 7
Other 54 3
‘Head’ includes eye, nose mouth and sinus; ‘skin and adnexa’ includes skin and
adnexa head, skin and adnexa (other), salivary gland, perianal gland, analsac,
axial, abaxial, extra-skeletal; ‘gastro-intestinal tract’ includes stomach, pancreas,
liver, bile duct, intestines; ‘endocrine organs’ includes adrenal gland, thyroid-
and parathyroid gland; ‘genital tract’ includes male and female reproduction
organs, ‘hematoproliferative system’ includes spleen, liver, thymus,
lymph nodes.
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years. Even considering a possible change in submission
rates in recent years, the low number of patients (1.8%)
that were sent in for both cytological diagnosis as well as
for histological diagnosis was still surprising, in particular
with respect to the importance of achieving an assessment
of grade and completeness of excision by histopathology
after getting a diagnosis of tumour type by cytology. Too
often – it appears - do veterinarians opt for either cytology
or histology for diagnostic purpose. A growing awareness
of the strength of combining both cytology and histology,
can perhaps in future change this observation.
Also based on our results we therefore believe that op-
timal veterinary care of dogs suspected of neoplasia is
best exerted by presurgical cytological examination of
FNABs followed by histopathology of resected masses
or, in cases deemed not manageable by surgery, by histo-
pathology of tissues biopsies if cytology was inconclu-
sive. Furthermore, such practice serves epidemiological
studies of neoplasia.
Age, sex and location
As is shown in Figure 1, the incidence for development
of a neoplasm was relatively low in younger animals, in-
creased sharply after the age of three, and peaked at 9
years for the histopathological- and at 10 years for the
cytological data-set. An age-dependent increase in inci-
dence for the development of a neoplasm is in agreement
with other studies [8,31,34]. Highest-peak-incidence was
noted at a younger age in the current study than peak-
incidence of cancers in a study in Italy (>12 years) [31]
but at a comparable age when compared with the study of
Dobson [34], which is remarkable, considering the poten-
tial bias for younger animals of this last study due to
different age-structure [23]. Also, as was the case in a
general dog-population studied in Denmark [19], benign
lesions occur at a younger age than malignant lesions in
both data-sets.
There is a significant difference (P < 0.001) in mean age
of animals when comparing the two data-sets. Even when
excluding CCH, a tumour reported to occur at a young
age [41] as was confirmed in our study (median age
2.8 years and 2.9 years, respectively, for the cytologically-
and histopathologically diagnosed tumours), this differ-
ence remained significant (P < 0.001). In accordance with
literature [19], there appeared no sex predisposition for
general tumour development. The data provided by the
submitting clinic did not consistently included neutering
status or date of neutering, prohibiting an examination on
the potential effect of age of neutering on tumour occur-
rence as published recently [29].
Taking a potential sampling bias for the occurrence
of tumours into account, since more common locations
are also more easily clinically accessible [8], the mostcommon locations of histological diagnosed tumours
were skin and adnexa (Table 4) which was also found in
earlier studies [12,17].
Veterinary cancer registries are few in number and
scattered [32,42]. Also, there is little information on age,
incidence, type, location and behavior of tumours in ca-
nine populations in general [32,42]. A population-based
cancer registry is preferred over a hospital-based cancer
registry, because it aims to represent all cases in a
known population [43], whereas hospital-based cancer
registries such as the ones in America [44,45] and Italy
[46] do not include cases that were seen only by primary
care veterinarians, risking a potential bias [47].
Much of what we know so far on tumour incidence
derives from the population-based veterinary cancer
registry in California, the California Animal Cancer
Registry (CANR) [32]. Results from this study are fre-
quently used as reference data set but are more than 40
years old and were obtained in one specific region only.
More recently, various studies came to rely on insur-
ance data, e.g. such as the ones in England [23,34] and
Sweden [48,49]. This kind of research could lead to a
potential age-related bias, since older dogs are less often
insured [34,50] and also excludes a presumed high por-
tion of dogs that are not insured at all [47]. Additionally,
diagnostic validation by histopathological or cytological
examination, in addition to a diagnosis based upon clin-
ical manifestation, is in some instances lacking. This
may lead to uncertainty regarding the accuracy of the re-
corded diagnosis [43]. As an alternative method, some
researchers have chosen to rely on veterinary cancer
Boerkamp et al. BMC Veterinary Research 2014, 10:34 Page 8 of 10
http://www.biomedcentral.com/1746-6148/10/34registries, like the study in Denmark [19], or question-
naires, such as studies in Norway [51] and Denmark
[16]. These approaches carry the risk of a voluntary bias,
because it is unlikely that owners report all tumours to
the registry [16,43]. Also, regarding surveys, the overall
response rate is expected to be only half the sample
population and includes a potential bias in responders
versus non-responders [51]. The Norwegian Canine
Cancer Register [52] and a study in Italy [31] tried to
improve the number of diagnosed cases by offering free
of charge histopathological examination of all tumours
of dogs in four counties. However, cytological examina-
tions were not included in this study, and studies that
offer free of charge will remain an exception due to fi-
nancial and logistical challenges.
In this study, we chose to assess the incidence of tu-
mours in one specific dog breed, with a centrally access-
ible source of diagnostic data using a broad system of
tumour classification. As was the case in other studies
[34], also in our study there was risk of a potential bias
in both numerator and denominator. In our study, the
strongest bias is most likely caused by the fact that not
all private clinicians have their biopsies evaluated at the
Utrecht University of Veterinary Medicine (UUVM).
Note that the two participating laboratories are not the
only diagnostic laboratories in the Netherlands. As sam-
ples numbers analysed by commercial laboratories are
confidential we can only make a best estimated guess
that some 20-40% and 40-50% of all histologically or
cytologically diagnosed tumours were evaluated, respect-
ively. This certainly will cause an underestimation of the
true incidence. On the other hand a potential overesti-
mation exists in the fact that the reference population is
composed of pedigree-dogs as registered at the Dutch
Kennel club, while biopsies in some cases derive from
dogs that are registered by owners as ‘Golden retrievers’
but that lack a pedigree.
In addition, an unknown portion of tumours remain
undiagnosed. Reason for this, is the fact that not all dogs
are presented to a veterinarian and not all owners are
willing to pursue and pay for a diagnostic work-up [52].
This situation is perhaps even more likely, if the popula-
tion at risk is not insured like the one used in this study.
We therefore consider the incidence rates found within
this study to be an estimation of the true incidence rate.
Most other studies take note of encountered bias, but
continue to register incidence rates (IR). Because of ex-
pected variations in both numerators and denominator,
it proved difficult to compare this EIR with IR found in
previous research [30,32,34,38,53,54]. Our EIR is lower
than the IR for tumour development in the general dog
population found in a Canadian study (IR: 3,965) but
this study makes use of a computerized medical record
system instead of only histopathological and cytologicaldata (Proceedings; The incidence of neoplasia in the
canine and patient populations of private veterinary
practices in Southern Ontario (2000) and therefore is
likely to have a very different denominator.
More comparable are the IR calculated for tumour
development in the general dog population (not breed-
specific) found by the CANR (IR:1,134) [30], a study in
England (IR: 1.948) [34], and a study in Italy (IR: 282)
[31]. The high EIR found in the present study when both
of the data-sets are combined (EIR: 2,242), could be an
indication of a breed-predisposition for general tumour
development in the Golden retriever.
Conclusions
The high EIR found in this study when evaluating com-
parable research is an indication of a breed-predisposition
for cancer as well as general tumour development in the
Golden retriever. The breed predisposition for MCT, NHL
and melanoma in Golden retrievers was confirmed. There
are also indications for a predisposition for STS.
Comparable to previous research that considered the
dog-population in general, benign lesions occur at a youn-
ger age than malignant tumours, and most tumours de-
velop in the skin. There appears no gender predilection.
Including diagnoses made through histopathology as well
as cytology, reduces the risk of a bias based on the diag-
nostic procedure of choice. A study combining both diag-
nostic procedures is therefore of greater value than a
study that focuses on a single diagnostic procedure.
Method
The experimental protocol (ID 2007.III.08.110) was
peer-reviewed by the scientific committee of the Depart-
ment of Animals in Science & Society, Utrecht Univer-
sity, The Netherlands, and approved by the Animal
Experiments Committee of the Academic Biomedical
Centre, Utrecht, The Netherlands. The Animal Experi-
ments Committee based its decision on ‘De Wet op de
Dierproeven’ (The Dutch ‘Experiments on Animals Act’,
1996) and on the ‘Dierproevenbesluit’ (the Dutch ‘animal
experiments decree’, 1996). Both documents are available
online at http://wetten.overheid.nl.
In this retrospective study, two separate data-sets were
used, consisting of either cytologically or histopathologic-
ally confirmed tumours from the client-owned pet-
population of Dutch Golden retrievers that were submitted
during the period 1998–2004 for cytological examination
to Utrecht University Veterinary Diagnostic Laboratory
(UVDL), or for histological examination during that period
to the Veterinary Pathologic Diagnostic Centre (VPDC).
Permission to use these data sets was obtained from the
Departments of the Veterinary Faculty concerned. As in
previous research [32] dog breeds were recorded as stated
by the owner. The material was obtained from patients
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ferral hospitals and private practitioners from all over the
Netherlands.
In incidental cases, when detailed information was un-
available, variables selected for investigation were age,
sex and, in the histopathological data-set, site of biopsy.
If in an animal multiple tumours were detected during
the period of the study, these were recorded as separate
incidences. A broad system of tumour classification was
applied for both data sets, which was based on tissue of
origin and actual diagnosis. All tumours were divided
into six (for the cytological data-set) or seven (for the
histopathological data-set) tissues of origin (mesenchy-
mal, hematopoietic, epithelial, neuroectodermal, gonadal
plus for the cytological tumours: malignant Not Other-
wise Specified (NOS) and for the histopathological data-
set: glial tumours and tumours that could be NOS).
Numerator and denominator
In total, 18,648 Golden retrievers (9,639 male dogs and
9,009 bitches) were registered between 1998 and 2004
in the Raad van Beheer (Dutch Kennel Club), the prin-
cipal cynological organization in the Netherlands. This
resulted in an average entry of 2,664 animals per year.
The Golden retriever reaches an average age of 11 years
(http://en.wikipedia.org/wiki/Golden_Retriever), so a cross-
sectional estimation of the total population during one year
is expected to be 11 * 2,664 = 29,304 (15,147 male dogs
and 14,157 bitches). This was defined denominator, or
population at risk (D).
The annual Estimated Incidence Rate (EIR) was calcu-
lated as the observed number of cases (C) in one year,








Input was considered as two separate data sets, and
thus two separate numerators were all neoplastic biop-
sies of dogs registered as ‘Golden retriever’ that were
sent during the given period to either the VPDC or the
UVDL. Results were used to calculate the occurrence of
neoplastic types in the two data sets and by calculation
of the number per annum corrected for the share of the
two laboratories of all submissions – to exclude double
counts - in the entire (with or without pedigree) Dutch
Golden Retriever population to assess an EIR.
Statistics
A Student’s t-test was used to test the age difference be-
tween malignant and benign tumours, a P < 0.05 was
considered to be significant. Normality and constancy of
variance of the data was evaluated by inspecting thehistograms. Statistical analyses were performed in R
library version 1.7 (http://cran.r-project.org).
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